Ginkgo Bioworks Holdings (DNA) Accumulated Depreciation & Amortization (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Accumulated Depreciation & Amortization data on file, last reported at $189.4 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 15.88% year-over-year to $189.4 million; the trailing twelve-month figure through Mar 2026 stood at $189.4 million (up 15.88% YoY), and the FY2025 full-year result was $187.9 million, up 16.81% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $189.4 million, up from $187.9 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $189.4 million in Q1 2026 and bottomed at $69.8 million in Q1 2022.
• The 5-year median for Accumulated Depreciation & Amortization is $130.1 million (2024), against an average of $133.3 million.
• The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 54.98%; it then climbed 14.99% in 2024.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $92.8 million in 2022, then surged by 30.15% to $120.7 million in 2023, then soared by 33.26% to $160.9 million in 2024, then climbed by 16.81% to $187.9 million in 2025, then grew by 0.78% to $189.4 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $189.4 million (Q1 2026), $187.9 million (Q4 2025), and $182.1 million (Q3 2025), per Business Quant data.

Peer Comparison